Everyone has experienced instances of their mind wandering away from tasks at hand. Recent evidence from UTCSP trainee Aaron Kucyi, in Dr. Karen Davis’ lab at Toronto Western Hospital, demonstrates that our minds wander even during pain, and that this is associated with increased engagement of pain-relieving pathways.
This study provides the first evidence indicating a role of gap junctions in trigeminal neuropathic pain. Whether these gap junctions are specific to glia requires further investigation. Given that carbenxolone is already used for the clinical treatment of ulcers, it has the potential to be a safe and effective drug for the clinical treatment of trigeminal neuropathic pain. Therefore, investigation of the efficacy of carbenxolone in treating pain in humans is necessary.
It Doesn't Have to Hurt: Strategies for Helping Children with Shots and Needles. A Youtube Video for Parents
How many times have your kids been upset about going to the doctor because they’re afraid of the pain that goes along with getting a needle? Every parent (and health professional) wants to know how getting a needle can be easier for everyone.
The Canadian STOP-PAIN project is a coalition of clinicians, nurses, and researchers from all over Canada, including UTCSP member Dr. Philip Peng, that conduct multidisciplinary research utilizing patients from all member hospitals and centers with the goal of better helping and treating patients with chronic pain. In this study, the STOP-PAIN project investigators looked at gender differences in the perception of reported pain, as well as impact on psychological well-being. The investigators also looked at differences in gender on the economic burden of chronic pain and its treatment.